Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13407706 | 0.87 | BACE1 (0.61) | BACE1LMNAHTTGRM2ALDH1A1 | |
| SCHEMBL7518412 | 0.86 | BACE1 (0.65) | BACE1LMNAHTTGRM2ALDH1A1 | |
| SCHEMBL7512580 | 0.86 | BACE1 (0.65) | BACE1LMNAHTTGRM2ALDH1A1 | |
| SCHEMBL7518108 | 0.86 | BACE1 (0.62) | BACE1LMNAHTTGRM2ALDH1A1 | |
| SCHEMBL7584937 | 0.82 | BACE1 (0.60) | BACE1LMNAHTTGRM2ALDH1A1 | |
| SCHEMBL17570159 | 0.81 | BACE1 (0.55) | BACE1LMNAHTT | |
| SCHEMBL14105052 | 0.80 | BACE1 (0.39) | BACE1LMNAHTTALDH1A1KMT2A | |
| SCHEMBL10120746 | 0.79 | BACE1 (0.65) | BACE1LMNAHTTGRM2ALDH1A1 | |
| SCHEMBL8265136 | 0.79 | BACE1 (0.38) | BACE1LMNAHTTALDH1A1KMT2A | |
| SCHEMBL12174372 | 0.78 | BACE1 (0.59) | BACE1LMNAHTTGRM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7700603-B2 | Heterocyclic aspartyl protease inhibitors | SCHERING CORPORATION (US) | 2010-04-20 | — | — | US | disclosed |
| US-7592348-B2 | Heterocyclic aspartyl protease inhibitors | SCHERING CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| WO-2006065277-A2 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS | SCHERING CORPORATION (US) | 2006-06-22 | — | — | WO | disclosed |